Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Parsa, M. A. Articles by Bastani, B. Search for Related Content PubMed Citation Articles by Parsa, M. A. Articles by Bastani, B. Parkinson's Disease

Quetiapine (Seroquel) in the Treatment of Psychosis in Patients With Parkinson's Disease

Received February 19, 1997; revised May 15, 1997; accepted May 20, 1997. From the Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio. Address correspondence to Dr. Parsa, Department of Psychiatry, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106.

Psychoses are a common clinical problem in patients with Parkinson's disease. Treatment with typical neuroleptics or withdrawal of antiparkinsonian drugs may improve mental symptoms but will worsen the parkinsonism. Quetiapine (Seroquel), ICI 204,636, is a novel antipsychotic medication with a low potential for producing extrapyramidal side effects. In this open-label clinical study of 2 patients with Parkinson's disease, treatment with Seroquel successfully controlled psychotic symptoms without worsening of motor disability.

Key Words: Quetiapine • Antipsychotic Medications • Parkinson's Disease

This article has been cited by other articles:

				M. L. Onor, M. Saina, and E. Aguglia Efficacy and Tolerability of Quetiapine in the Treatment of Behavioral and Psychological Symptoms of Dementia American Journal of Alzheimer's Disease and Other Dementias, January 1, 2007; 21(6): 448 - 453. [Abstract] [PDF]

				F. Fernandez Ten Myths About HIV Infection and Aids Focus, April 1, 2005; 3(2): 184 - 193. [Full Text] [PDF]

				R Katzenschlager, A J Manson, A Evans, H Watt, and A J Lees Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 295 - 297. [Abstract] [Full Text] [PDF]

				B. R. Sommer Quetiapine-Induced Extrapyramidal Side Effects in Patients with Parkinson's Disease: Case Report J Geriatr Psychiatry Neurol, June 1, 2001; 14(2): 99 - 100. [Abstract] [PDF]

				I. H. Richard and J. Nutt Worsening of motor function in Parkinson's disease: A ""typical"" response to ""atypical"" antipsychotic medications Neurology, September 26, 2000; 55(6): 748 - 749. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us